Modification of estrogen's association with Alzheimer's disease risk by genetic polymorphisms

Brain Research

Volumn 1379, Issue , 2011, Pages 213-223

  Thornton, V ^a   Warden, D ^b   Talbot, C ^c   S s mastana, ^a   Bandelow, S ^a   Hogervorst, E ^a  

^a LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Alzheimer's disease; APOE gene; COMT gene; Estradiol; Estrone

Indexed keywords

APOLIPOPROTEIN E; CATECHOL METHYLTRANSFERASE; ESTRADIOL; ESTROGEN;

AGED; ALLELE; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ARTICLE; BLOOD SAMPLING; BODY MASS; COGNITION; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HORMONAL THERAPY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CATECHOL O-METHYLTRANSFERASE; ESTRADIOL; ESTROGENS; FEMALE; GENE FREQUENCY; HUMANS; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 79952310962     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.12.074     Document Type: Article

References (36)

1. Arvanitakis, Z., Wilson, R.S., Bienias, J.L., Evans, D.A., Bennett, D.A., 2004. Diabetesmellitus and risk of Alzheimer's disease and decline in cognitive function. Arch. Neurol. 61 (5), 661-666.
2. Borroni, B., Agosti, C., Archetti, S., Costanzi, C., Bonomi, S., Ghianda, D., Lenzi, G.L., Caimi, L., Luca, M.D., Padovani, A., 2004. Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer's disease. Neurosci. Lett. 370, 127-129.
3. Borroni, B., Grassi, M., Costanzi, C., Zanetti, M., Archetti, S., Franzoni, S., Cami, L., Padovani, A., 2007. Haplotypes in catechol-O- methyltransferase gene confer increased risk of psychosis in Alzheimer disease. Neurobiol. Aging 1231-1238. (Pubitemid 46824011)
4. Brinton, R.D., 2008. The healthy cell bias of estrogen action. Trends in Neuroscience. 31 (10), 529-537.
5. Cunningham, C.J., Sinnott, M., Deniham, A., Rowan, M., Walsh, J.B., O'Moore, R., Coakley, D., Coen, R.F., Lawler, B.A., O'Neill, D.D., 2001. Endgoenous sex hormone levels in postmenopausal women with AD. J. Clin. Endocrinol. Metab. 86 (3), 1099-1103.
6. Dowsett, M., Goss, P.E., Powles, T.J., Hutchinson, G., Brodie, A.M., Jeffcoate, S.L., Coombes, R.C., 1987. Use of aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Res. 135, 1220-1230.
7. Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., Myers, R.H., Pericak-Vance, M.A., Risch, N., van Dujjn, C.M., 1997. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278 (16), 1349-1356.
8. Folstein, M.F., Folstein, S.E., McHugh, P.R., 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (3), 189-198.
9. Forero, D.A., Benitez, B., Arboleda, G., Yunis, J.J., Pardo, P., Arboleda, H., 2006. Analysis of functional polymorphisms in three synaptic plasticity-related genes (BDNF, COMT, AND UCHL1) in Alzheimer's disease in Columbia. Neurosci. Res. 55, 334-341.
10. Hironi, H., Hashimoto, M., Yasuda, M., Kazui, H., Mori, E., 2003. Acceleratedmemory decline in Alzheimer's disease with apolipoprotein E ∈4 allele. J. Neuroppsychiatry Clin. Neurosci. 15, 354-358.
11. Hogervorst, E., Bandelow, S., 2009. Brain and cognition. Is there any case for improving cognitive function in menopausal women using estrogen treatment? Minerva Ginecol. 61 (6), 499-515.
12. Hogervorst, E., Bandelow, S., 2010. Sex steroids to maintain cognitive function in women after the menopause: a meta-analyses of treatment trials. Maturitas 66 (1), 56-71.
13. Hogervorst, E., Williams, J., Budge, M., Riedel, W., Jolles, J., 2000. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience 101 (3), 485-512.
14. Hogervorst, E., Williams, J., Combrinck, M., Smith, A.D., 2003a. High levels of serum estradiol in women with Alzheimer's disease: the importance of the sensitivity of the assay method. Eur. J. Clin. Endo. 148, 67-72.
15. Hogervorst, E., Bandelow, S., Combrinck, M., Irani, S., Smith, A.D., 2003b. The validity and reliability of 6 sets of clinical criteria to classify Alzheimer's disease and vascular dementia in post-mortemconfirmed cases: added value of a decision-tree approach. Dementia 16 (3), 170-180. (Pubitemid 36737004)
16. Hogervorst, E., Henderson, V., Gibbs, R., Brinton, R., 2009. Hormones, Cognition and Dementia. State of the Art and Emergent Therapeutic Strategies. Cambridge University Press, Cambridge.
17. Hoskin, E.K., Tang, M.X., Manly, J.J., Mayeux, R., 2004. Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease. Neurobiol. Aging 25, 141-147. (Pubitemid 38121687)
18. Launer, L.J., Anderson, K., Dewey, M.E., Letenneaur, L., Ott, A., Amaducci, L.A., Brayne, C., Copeland, J.R.M., Dartigues, J.F., Kragh-Sorensen, P., Lobo, A., Martinez-Lage, J.M., Stijnen, T., Hofman, A., 1999. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology 52, 78.
19. Lukanova, A., Lundin, E., Zeleniuch-Jacquotte, A., Muti, P., Mure, A., Rinaldi, S., Dossus, L., Michell, A., Arslan, A., Lenner, P., Shore, R.E., Krogh, V., Kroenig, K.L., Riboli, E., Berrino, F., Hallmans, G., Stattin, P., Toniolo, P., Kaaks, R., 2004. Body mass index, circulating levels of sex steroid hormones, IGF-I and IGF-binding protein-3: a cross sectional study in healthy women. Eur. J. Endocrinol. 150 (2), 161-171.
20. Martínez, F., Martín, X., Alcelay, L., Flores, J., Valiente, J., Juanbeltz, B., Beldarraín, M., López, J., Gonzalez-Fernández, M., Salazar, A., Gandarias, R., Borda, S., Marqués, N., Amillano, M., Zabaleta, M., de Pancorbo, M., 2009. The COMT Val 158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers. BMC Neurosci. 10, 125.
21. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., Stadlan, E.M., 1984. Clinical diagnoses of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (7), 939-944.
22. Muller, M., Schupf, N., Manly, J.J., Mayeux, R., Luchsinger, J.A., 2008. Sex hormone binding globulin and incident Alzheimer's disease in elderly men and women. Neurobiol. Ageing. doi:10.1016/j.neurobioaging.2008.10.001.
23. Nicholl, D.J., Bennett, P., Hiller, L., et al., 1999.Astudy of five candidate genes in Parkinson's disease and related neurodegenerative disorders. Neurology 53 (7), 1415-1421. (Pubitemid 29491930)
24. Paoletti, A.M., Congia, S., Lello, S., Tedde, D., Orru, M., Pistis, M., Pilloni, M., Zedde, P., Loddo, A., Melis, G.B., 2004. Low androgenisation index in elderly women and elderly men with Alzheimer's disease. Neurology 62, 301-303. (Pubitemid 38167146)
25. Ropacki, S.A., Jeste, D.V., 2005. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am. J. Psychiatry 162, 2022-2030. (Pubitemid 41598255)
26. Roth, M., Tym, E., Mountjoy, C.Q., Huppert, F.A., Hendrie, H., Verma, S., Goddard, R., 1988. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the elderly detection of dementia. Br. J. Psychiatry 149, 698-709.
27. Shumaker, S.A., Legault, C., Rapp, S.R., et al., 2003. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (20), 2651-2662. (Pubitemid 37430136)
28. Srivastava, R.A., Srivastava, N., Averna, M., Lin, R.C., Korach, K.S., Lubahn, D.B., Schonfeld, G., 1997. Estrogen up-regulates apolipoprotein E (ApoE) gene expression by increasing ApoE mRNA in the translating pool via the estrogen receptor alpha-mediated pathway. J .Biol. Chem. 272 (52), 33360-33366. (Pubitemid 28023687)
29. Stern, Y., Gurland, B., Tatemichi, T.K., Tang, M.X., Wilder, D., Mayeux, R., 1994. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA 271 (13), 1004-1010. (Pubitemid 24099921)
30. Teter, B., Harris-White, M.E., Frautschy, S.A., Cole, G.M., 1999. Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures. Neuroscience 91, 1009-1016. (Pubitemid 29225631)
31. Tunbridge, E.M., Harrison, P.J., Warden, D.R., Johnston, C., Refsum, H., Smith, A.D., 2008 Sep 5. Polymorphisms in the catechol-O-methyltransferase (COMT) gene influence plasma total homocysteine levels. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B (6), 996-999.
32. Tworoger, S., Chubak, J., Aiello, E., Ulrich, C., Atkinson, C., Potter, J., Yasui, Y., Stapleton, P., Lampe, J., Farin, F., Stanczyk, F., McTiernan, A., 2004. Association of CYP17, CYP19, CYP1B1, and COMT polymorphisms with serum and urinary sex hormone concentrations in postmenopausal women. Cancer Epidemiol. Biomark. Prev. 13, 94-101.
33. Wang, P., Liu, H., Chu, A., Hong, C., Lin, K., Chi, C., 2004. Estrogen-metabolizing gene COMT polymorphism synergistic APOE ∈4 allele increases the risk of Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 19, 120-125.
34. Worda, C., Sator, M., Schneeberger, C., Jantschev, T., Ferlitsch, K., Huber, J., 2003. Influence of the catechol-O-methyltransferase (COMT) codon 158 polymorphism on estrogen levels in women. Hum. Reprod. 18 (2), 262-266.
35. Yaffe, K., Haan, M., Byers, A., Tangen, C., Kuller, L., 2000. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54, 1949-1954.
36. Yagi, E., Barrett, J.C., Tsutsui, T., 2001. The ability of four catechol estrogens of 17beta-estradiol and estrone to induce DNA adducts in Syrian hamster embryo fibroblasts. Carcinogenesis 22, 1505-1510. (Pubitemid 32898708)